ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1,4,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3,1,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
3,2,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
5,2,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
5,6,Listless,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
6,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
6,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
6,4,Listless,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
6,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
7,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
8,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
8,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
9,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
9,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
10,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
11,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,1,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
13,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
13,2,Spinal cord haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
14,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
16,1,Small intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
17,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
17,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
17,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
17,5,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
17,6,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
17,7,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
18,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
18,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
18,3,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
18,4,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
18,5,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
19,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
19,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
19,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
21,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
22,1,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,Y
23,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
23,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
23,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
23,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
23,6,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
23,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
23,8,Thrombolysis,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
23,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
24,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
25,1,Duodenitis haemorrhagic,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
25,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
25,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
26,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
26,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
26,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
26,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
26,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
26,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
26,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
27,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
28,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
29,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
29,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
30,1,Cerebral mass effect,Structural brain disorders NEC,Structural brain disorders,Nerv,N
30,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
30,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
31,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
31,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
31,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
32,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
32,2,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
32,3,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
32,4,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
33,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
33,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
34,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
35,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
35,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
35,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
36,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
37,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
37,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
37,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
38,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
39,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
39,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
40,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
40,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
40,3,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
40,4,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
40,5,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
40,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
40,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
40,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
40,9,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
41,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
41,2,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
41,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
41,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
41,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
41,6,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
41,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
42,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
43,1,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
43,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
44,1,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
44,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
44,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
45,1,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
46,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
46,2,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
46,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
47,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
47,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
48,1,Dandy-Walker syndrome,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
48,2,Fallot's tetralogy,Multiple cardiac abnormalities congenital,Cardiac and vascular disorders congenital,Cong,N
48,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
49,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
49,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
50,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
50,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
51,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
51,2,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
51,3,Umbilical cord prolapse,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
52,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
52,2,Intensive care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
52,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
53,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
53,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
54,1,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
55,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
55,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
56,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
56,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
56,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
56,4,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
56,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
57,1,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
58,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
58,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
58,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
58,4,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
59,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
60,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
60,2,Respiratory tract haemorrhage,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
60,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
61,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
62,1,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
62,2,Removal of foreign body,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
63,1,Catheter site haemorrhage,Implant and catheter site reactions,Administration site reactions,Genrl,N
63,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
63,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
63,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
64,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
65,1,Capillary fragility test,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
66,1,Capillary fragility test,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
67,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
67,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
67,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
67,4,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
67,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
67,7,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
68,1,Urticaria chronic,Urticarias,Angioedema and urticaria,Skin,N
69,1,Capillary fragility test,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
70,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
70,2,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
70,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
70,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
70,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
71,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
72,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
73,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
74,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
75,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
76,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
76,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
76,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
77,1,Headache,Headaches NEC,Headaches,Nerv,N
78,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
78,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
78,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
78,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
78,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
78,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
78,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
78,8,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
79,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
80,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
80,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
80,4,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
80,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
80,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
80,7,Refeeding syndrome,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
80,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
80,9,Renal vascular thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
80,10,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
81,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
81,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
81,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
82,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,1,Enlarged uvula,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
83,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
83,3,Oral mucosal erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
84,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
84,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
84,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
84,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
85,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
86,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
86,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
86,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
86,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
87,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
88,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
89,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
89,2,Eczema impetiginous,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
89,3,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
89,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
89,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,7,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
89,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
90,1,Headache,Headaches NEC,Headaches,Nerv,N
90,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
90,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
90,4,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
91,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
91,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
91,3,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
91,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
91,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
91,6,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
91,7,Headache,Headaches NEC,Headaches,Nerv,N
91,8,Headache,Headaches NEC,Headaches,Nerv,N
91,9,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
91,10,Hypofibrinogenaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
91,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,12,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
91,13,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
91,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
91,15,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
91,16,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
91,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
93,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,2,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
94,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
94,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
94,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
94,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
95,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
95,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
95,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
96,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
97,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
98,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
98,2,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
98,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,4,Pancreatitis haemorrhagic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
98,5,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
99,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
101,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
102,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
103,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
103,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
104,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
104,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
105,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
105,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
106,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
